NCS Multistage reported Q4 2025 total revenues of USD 50.6 million (+13%), with operating income of USD 5.2 million (+78%) and net income of USD 15.0 million, including a USD 9.8 million net positive impact from releasing its deferred tax valuation allowance. Q4 adjusted EBITDA was USD 9.2 million, and the company ended 2025 with USD 36.7 million in cash and USD 7.6 million in debt. For FY 2025, NCS Multistage posted total revenues of USD 183.6 million (+13%), operating income of USD 10.5 million (more than doubled), and net income of USD 23.7 million, including a USD 11.5 million net positive impact from the deferred tax valuation allowance release. FY adjusted EBITDA was USD 26.7 million (+20%) and free cash flow after distributions to non-controlling interest was USD 18.9 million. Business highlights included the July 31, 2025 acquisition of Reservoir Metrics (ResMetrics), which contributed USD 5.2 million to 2025 services revenue and USD 2.8 million in Q4 services revenue, strengthening NCS Multistage’s tracer diagnostics offering and expanding its presence in Middle East markets. Management said it expects a challenging 2026 market environment, with lower year-over-year U.S. customer activity, relatively flat Canada activity, and international improvements weighted to the second half, particularly in the Middle East.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NCS Multistage Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603041605PRIMZONECNPR____9665959) on March 04, 2026, and is solely responsible for the information contained therein.